← Open Payments lookup

ROBERT WOODHAM: Open Payments

NPI 1578621223 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,174 in 158 payments from 15 companies in 2025. Trend: 2023 $2,415 · 2024 $2,484 · 2025 $3,174

Food & beverage: $3,172Education: $2
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)30$522
Otsuka America Pharmaceutical, Inc.20$339
Neurocrine BioSciences, Inc.10$321
Alkermes, Inc.11$289
Lundbeck LLC12$278
Takeda Pharmaceuticals U.S.A., Inc.11$238
Corium, LLC15$232
Teva Pharmaceuticals USA, Inc.16$212
Janssen Pharmaceuticals, Inc9$198
ABBVIE INC.13$187

Products named: CAPLYTA, REXULTI, INGREZZA, ARISTADA, TRINTELLIX, Azstarys, VRAYLAR, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.